Xenetic Biosciences to acquire Santersus AG in all-stock deal Sep 16, 2026 07:01AM
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics Sep 16, 2026 07:00AM
Xenetic Biosciences prices $4.5 million stock offering at $6.12 per share Oct 10, 2025 09:31AM
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock Oct 10, 2025 09:30AM